These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22938401)

  • 21. Association of interleukin-8 and plasminogen activator system in the progression of colorectal cancer.
    Terada H; Urano T; Konno H
    Eur Surg Res; 2005; 37(3):166-72. PubMed ID: 16088182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of matrix metalloproteinase expression in colorectal carcinomas.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2000; 14(5):659-66. PubMed ID: 11212843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets.
    Hadler-Olsen E; Winberg JO; Uhlin-Hansen L
    Tumour Biol; 2013 Aug; 34(4):2041-51. PubMed ID: 23681802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis.
    Yoon WH; Jung YJ; Kim TD; Li G; Park BJ; Kim JY; Lee YC; Kim JM; Park JI; Park HD; No ZS; Lim K; Hwang BD; Kim YS
    Clin Cancer Res; 2004 Jul; 10(13):4517-26. PubMed ID: 15240544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urokinase receptor and vascular endothelial growth factor are synergistically associated with the liver metastasis of colorectal cancer.
    Konno H; Abe J; Kaneko T; Baba M; Shoji A; Sunayama K; Kamiya K; Tanaka T; Suzuki S; Nakamura S; Urano T
    Jpn J Cancer Res; 2001 May; 92(5):516-23. PubMed ID: 11376560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
    Minoo P; Baker K; Baumhoer D; Terracciano L; Lugli A; Zlobec I
    Hum Pathol; 2010 Jan; 41(1):70-8. PubMed ID: 19740518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
    Tummalapalli P; Gondi CS; Dinh DH; Gujrati M; Rao JS
    Int J Oncol; 2007 Jul; 31(1):5-17. PubMed ID: 17549400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progression of Osteosarcoma from a Non-Metastatic to a Metastatic Phenotype Is Causally Associated with Activation of an Autocrine and Paracrine uPA Axis.
    Endo-Munoz L; Cai N; Cumming A; Macklin R; Merida de Long L; Topkas E; Mukhopadhyay P; Hill M; Saunders NA
    PLoS One; 2015; 10(8):e0133592. PubMed ID: 26317203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis.
    Choong PF; Nadesapillai AP
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S46-58. PubMed ID: 14600592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression.
    Baker EA; Bergin FG; Leaper DJ
    Mol Pathol; 2000 Dec; 53(6):307-12. PubMed ID: 11193049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression.
    Jodele S; Blavier L; Yoon JM; DeClerck YA
    Cancer Metastasis Rev; 2006 Mar; 25(1):35-43. PubMed ID: 16680570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The involvement of matrix metalloproteinases in the development and progression of neoplasm diseases].
    Chojnacki M; Zając A; Pięt M
    Postepy Biochem; 2017; 63(4):277-286. PubMed ID: 29374429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urokinase type plasminogen activator receptor expression in colorectal neoplasms.
    Suzuki S; Hayashi Y; Wang Y; Nakamura T; Morita Y; Kawasaki K; Ohta K; Aoyama N; Kim SR; Itoh H; Kuroda Y; Doe WF
    Gut; 1998 Dec; 43(6):798-805. PubMed ID: 9824607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of matrix metalloproteinases in melanoma cell invasion.
    Hofmann UB; Houben R; Bröcker EB; Becker JC
    Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors.
    Ahmad A; Wang Z; Kong D; Ali S; Li Y; Banerjee S; Ali R; Sarkar FH
    Breast Cancer Res Treat; 2010 Jul; 122(2):337-46. PubMed ID: 19813088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the plasminogen activation system in angiogenesis and metastasis.
    Rabbani SA; Mazar AP
    Surg Oncol Clin N Am; 2001 Apr; 10(2):393-415, x. PubMed ID: 11382594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.
    Pavón MA; Arroyo-Solera I; Céspedes MV; Casanova I; León X; Mangues R
    Oncotarget; 2016 Aug; 7(35):57351-57366. PubMed ID: 27385000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invasion and metastasis in pancreatic cancer.
    Ellenrieder V; Adler G; Gress TM
    Ann Oncol; 1999; 10 Suppl 4():46-50. PubMed ID: 10436784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paris saponin VII inhibits metastasis by modulating matrix metalloproteinases in colorectal cancer cells.
    Fan L; Li Y; Sun Y; Yue Z; Meng J; Zhang X; Zhang R; Zhang D; Zhang F; Mei Q
    Mol Med Rep; 2015 Jan; 11(1):705-11. PubMed ID: 25333739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.